newsroom

MedTrax Inc Provides Crucial DSCSA Compliance Solutions Ahead Of Full Enforcement Deadline

Verified Article
USANews May 27, 2025
Share Share on Facebook Share on Twitter
MedTrax Inc Provides Crucial DSCSA Compliance Solutions Ahead Of Full Enforcement Deadline
Nationwide (USANews) MedTrax Inc has emerged as a trusted provider of software solutions specifically designed to ensure pharmacy compliance with the Drug Supply Chain Security Act (DSCSA). As the final enforcement date for DSCSA draws near, MedTrax is offering critical infrastructure and technology to help dispensers, wholesalers, and manufacturers meet federal requirements and avoid regulatory penalties. Based in the United States and supported by the experienced team at Outdate Rx, MedTrax delivers cost-effective and secure systems for pharmaceutical supply chain accountability. The DSCSA was signed into law in 2013 with the aim of securing the nation’s pharmaceutical supply chain. It was introduced to prevent the distribution of counterfeit, stolen, contaminated, or otherwise unsafe prescription drugs to the American public. Central to the DSCSA mandate is the electronic transmission and maintenance of drug pedigree information — records that detail the origin and transactional history of pharmaceutical products. This law affects manufacturers, wholesale distributors, dispensers (such as retail pharmacies), and third-party logistics providers. As of November, full compliance with the DSCSA will become mandatory. This includes several key provisions: manufacturers and wholesalers must transmit serialized transaction information electronically to their purchasers; dispensers must store this pedigree information in a secure, interoperable, and tamper-evident database; and trading partners must be verified and authorized under FDA guidelines. Furthermore, DSCSA mandates that all suspicious products be reported to the FDA via form 3911, and that compliance data be retained for a minimum of six years. Regulatory enforcement has already begun. The U.S. Food and Drug Administration (FDA) has cited several entities for failing to adhere to DSCSA mandates. McKesson Health in San Francisco was cited for not reporting tampered products. Safe Chain Solutions received violations for engaging with unauthorized trading partners and failing to notify the FDA of suspect medications. Valisure was found to have neglected proper investigation and failed to submit required form 3911 documentation. These violations underline the serious legal and operational risks facing pharmacies that have not yet aligned their systems with DSCSA compliance standards. MedTrax’s software platform directly addresses the full spectrum of these requirements. Designed with input from pharmacy professionals and built on decades of industry experience, the MedTrax system provides secure, end-to-end compliance tools tailored for dispensers. With features including two-factor authentication, multi-layered security, secure encrypted AS2 data transmission, and 24/7 availability, the platform ensures pharmacies maintain verifiable, tamper-proof records. In addition, the system logs all user activity to promote accountability and compliance with FDA audit requirements. A major benefit of the MedTrax platform is its integration with manufacturers and wholesalers, enabling seamless and automated pedigree receipt. Users can verify trading partners with a single click, electronically submit and receive FDA form 3911 reports, and rely on redundant backup systems for uninterrupted access to their compliance records. These technical capacities make MedTrax a practical solution for pharmacies seeking a comprehensive approach to DSCSA readiness. Among the advanced tools MedTrax offers are features that enhance daily operations while supporting compliance. The system’s multi-scan functionality allows users to process entire orders with a single scan, dramatically reducing the time needed for inventory intake. Integrations with pharmacy management systems further simplify compliance by turning complex verification and reporting tasks into background processes. MedTrax also employs EPCIS (Electronic Product Code Information Services) standards to track drug movement in three dimensions — including origin, co-shipping history, and final destination — ensuring traceability across the entire supply chain. In addition to compliance, MedTrax offers tools to improve pharmacy efficiency and cost savings. The platform includes functionality to manage expired medications and initiate returns, often generating significant financial returns for users. The recall alert feature, powered by data from the National Recall Alert Center, cross-references pharmacy inventory with recall announcements to identify affected products instantly. These combined capabilities have made MedTrax a valued resource for pharmacies navigating an increasingly complex regulatory environment. President Jacob Record emphasized the urgency of compliance as the final DSCSA requirements approach. “The industry has had over a decade to prepare, but many pharmacies remain unaware of how close the deadline is and how serious the consequences can be,” he stated. “MedTrax was designed to help pharmacies transition into compliance quickly and affordably. For about a dollar a day, pharmacies can secure their operations and avoid the fines, license suspensions, and even criminal charges that come with non-compliance.” MedTrax’s differentiation in the market stems not only from its technology, but also from the deep experience of its team. Backed by Outdate Rx, a company with decades of experience assisting pharmacies with recalls, reverse distribution, and compliance services, MedTrax was built with real-world pharmacy workflows in mind. This perspective enabled the company to build a compliance platform that is both technically rigorous and user-friendly. While the DSCSA compliance space is still developing, MedTrax has positioned itself as one of the top solutions providers in the market. Its core advantages — affordability, system efficiency, and unparalleled industry knowledge — give it a competitive edge as pharmacies race to meet federal deadlines. The company’s proactive approach and ongoing collaboration with supply chain stakeholders ensures its platform remains current with evolving industry standards and regulatory updates. As the November deadline nears, the importance of compliance cannot be overstated. Pharmacies that delay may face significant legal and financial repercussions. MedTrax provides not just a software solution, but a full-service compliance partner committed to safeguarding public health and ensuring the integrity of the pharmaceutical supply chain. More information about MedTrax’s services and DSCSA compliance tools is available on the company’s website: www.medtrax.com/promo.
Fresh off the press!
Sign up to get the best of USA News delivered straight to your email every morning!